Competitor arises for Martin Shkreli’s Daraprim – at $1 a pill
San Diego's Imprimis Pharmaceuticals could give Martin Shkreli a run for his money - offering an alternative to the egregiously high cost Daraprim at $1 a pill.
San Diego's Imprimis Pharmaceuticals could give Martin Shkreli a run for his money - offering an alternative to the egregiously high cost Daraprim at $1 a pill.